Angela Hwang Joins Flagship Pioneering as CEO-Partner and CEO of Metaphore Biotechnologies

Appointment:
Angela Hwang, former Chief Commercial Officer and President of the Global Biopharmaceuticals Business at Pfizer, has been appointed as CEO-Partner at Flagship Pioneering and Chief Executive Officer of Metaphore Biotechnologies, effective January 1, 202514.

Experience:
Hwang brings over 27 years of experience from Pfizer, where she played a pivotal role in launching 600 medicines and vaccines across 185 countries, including the world's first COVID-19 vaccine and the first oral antiviral treatment12.

Leadership Impact:
At Pfizer, Hwang led a team of 26,000 colleagues and was instrumental in addressing major global health priorities such as cancer, infectious diseases, and rare diseases. She also executed numerous business development deals to expand Pfizer's portfolio12.

Metaphore's Focus:
Metaphore Biotechnologies uses machine learning and molecular mimicry to design novel therapeutics. Hwang's leadership is expected to drive growth and innovation in this area1.

Recent Collaboration:
Metaphore recently announced a research collaboration with Novo Nordisk to develop next-generation therapeutics for obesity management using Metaphore's MIMIC platform1.

Sources:

1. https://www.prnewswire.com/news-releases/flagship-pioneering-appoints-angela-hwang-as-ceo-partner-and-chief-executive-officer-of-metaphore-biotechnologies-302310568.html

2. https://reddoorcommunity.org/angela-hwang/

4. https://www.flagshippioneering.com/news/press-release/flagship-pioneering-appoints-angela-hwang-as-ceo-partner-and-chief-executive-officer-of-metaphore-biotechnologies